Molecular diagnostics in monogenic and multifactorial forms of Type 2 diabetes

References

• Groop L, Orho-Melander M. The dysmetabolic syndrome. J. Intern. Med. 250, 105–120 (2001).
   Google Scholar
• McCarty D, Zimmet P. Diabetes 1994 to 2010: global estimates and projections. Bayer AG, Leverkusen and International Diabetes Institute, Melbourne, Australia. (1994).
   Google Scholar
• Montague CT, ORahilly S. The perils of portliness: causes and consequences of visceral adiposity. Diabetes 49, 883–888 (2000).
   Google Scholar
• UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with Type 2 diabetes (UKPDS33). Lancet 352, 837–853 (1998).
   Google Scholar
• Gloyn AL, McCarthy MI. The genetics of Type 2 diabetes. Best Pract. Res. Clin. Endocrinol. Met. 15, 293–308 (2001).
   Google Scholar
• • An up-to-date review of the status of efforts to identify etiological genes for T2D.
   Google Scholar
• Tattersall RB. Mild familial diabetes with dominant inheritance. Quart. J. Med. 43, 339–357 (1974).
   Google Scholar
• Hattersley AT. Maturity-onset diabetes of the young: clinical heterogeneity explained by genetic heterogeneity. Diabet. Med. 15, 15–24 (1998).
   PubMedGoogle Scholar
• • A discussion of relationships between genotype and phenotype in MODY subtypes.
   Google Scholar
• Tattersall RB, Mansell PI. Maturity onsettype diabetes of the young (MODY): one condition or many? Diabet. Med. 8, 402–410 (1991).
   Google Scholar
• Froguel P, Vaxillaire M, Sun F et al. Close linkage of glucokinase locus on chromosome 7p to early-onset noninsulin- dependent diabetes mellitus. Nature 356, 162–164 (1992).
   Google Scholar
• Hattersley AT, Turner RC, Permutt MA et al. Linkage of Type 2 diabetes to the glucokinase gene. Lancet 339, 1307–1310 (1992).
   Google Scholar
• Yamagata K, Oda N, Kaisaki PJ et al. Mutations in the hepatic nuclear factor 1 alpha gene in maturity-onset diabetes of the young (MODY3). Nature 384, 455–458 (1996).
   Google Scholar
• Yamagata K, Furuta H, Oda N et al. Mutations in the hepatocyte nuclear factor 4 gene in maturity-onset diabetes of the young (MODY1). Nature 384, 458–460 (1996).
   Google Scholar
• Horikawa Y, Iwasaki N, Hara M et al. Mutation in hepatocyte nuclear factor-1– gene TCF2 associated with MODY. Naure Genet. 17, 384–385 (1997).
   Google Scholar
• Stoffers DA, Ferrer J, Clarke WL & Habener JF. Early-onset type-II diabetes mellitus (MODY4) linked to IPF1. Nature Genet. 17, 138–139 (1997).
   Google Scholar
• Froguel P, Zouali H, Vionnet N et al. Familial hyperglycemia due to mutations in glucokinase. Definition of a subtype of diabetes mellitus. N. Engl. J. Med. 328, 697–702 (1993).
   PubMedGoogle Scholar
• Page RC, Hattersley AT, Levy JC et al. Clinical characteristics of subjects with a missense mutation in glucokinase. Diabet. Med. 12, 209–217 (1995).
   Google Scholar
• Byrne MM, Sturis J, Clement K et al. Insulin secretory abnormalities in subjects with hyperglycemia due to glucokinase mutations. J. Clin. Invest. 93, 1120–1130 (1994).
   Google Scholar
• Sovik O, Njolstad P, Folling I, Sagen J, Cockburn BN, Bell GI. Hyperexcitability to sulphonylurea in MODY3. Diabetologia 41, 607–608 (1998).
   Google Scholar
• Pearson ER, Liddell WG, Shepherd M et al. Sensitivity to sulfonylureas in patients with hepatocyte nuclear factor 1 gene mutations: evidence for pharmacogenetics in diabetes. Diabet. Med. 17, 543–545 (2000).
   Google Scholar
• Pontoglio M, Prie D, Cheret C et al. HNF1 controls renal glucose reabsorption in mouse and man. EMBO Rep. 1, 359–365 (2000).
   Google Scholar
• Lehto M, Bitzen PO, Isomaa B et al. Mutation in the HNF-4 gene affects insulin secretion and triglyceride metabolism. Diabetes 48, 423–425 (1999).
   Google Scholar
• Bingham C, Ellard S, Allen L et al. Abnormal nephron development associated with a frameshift mutation in the transcription factor HNF-1. Kidney Int. 57, 898–907 (2000).
   PubMedGoogle Scholar
• Bingham C, Bulman M, Ellard S et al. Mutations in the HNF1- gene are associated with familial hypoplastic glomerulocystic kidney disease. Am. J. Hum. Genet. 68, 219–224 (2001).
   Google Scholar
• Pearson ER, Velho G, Clark P et al. Betacell genes and diabetes: quantitative and qualitative differences in the pathophysiology of hepatic nuclear factor 1- and glucokinase mutations. Diabetes 50, S101–S107 (2001).
   Google Scholar
• • A detailed description of how understanding the molecular basis of different subtypes of MODY has helped to explain the heterogeneity in disease phenotypes.
   Google Scholar
• Frayling, TM, Bulman MP, Ellard S et al. Mutations in the Hepatocyte nuclear factor 1 gene are a common cause of maturityonset diabetes of the young in the United Kingdom. Diabetes 46, 720–725 (1997).
   Google Scholar
• Kaisaki PJ, Menzel S, Lindner T et al. Mutations in the Hepatocyte nuclear factor 1– Gene in MODY and Early-onset NIDDM: Evidence for a Mutational Hotspot in Exon 4. Diabetes 45, 528–535 (1997).
   Google Scholar
• Shepherd M, Ellis I, Ahmad AM et al. Predictive genetic testing in maturity-onset diabetes of the young (MODY). Diabet. Med. 18, 417–421 (2001).
   Google Scholar
• • An illuminating description of the ethical issues involved in predictive genetic testing for MODY based on one familys experience.
   Google Scholar
• Shepherd M, Sparkes AC & Hattersley AT. Genetic testing in maturity onset diabetes of the young (MODY): a new challenge for the diabetic clinic. Practical Diabetes 18, 16–21 (2001).
   Google Scholar
• Ellard S, Beards F, Allen LIS et al. A high prevalence of glucokinase mutations in gestational diabetic subjects selected by clinical criteria. Diabetologia 43, 250–253 (2000).
   Google Scholar
• Hattersley AT, Beards F, Ballantyne E et al. Mutations in the glucokinase gene of the fetus result in reduced birth weight. Nature Genet. 19, 268–270 (1998).
   Google Scholar
• •• A study of the effects of glucokinase variation on fetal growth and proof-ofprinciple that genetic variation can explain the relationships between low birth weight and diabetes previously attributed exclusively to metabolic programming.
   Google Scholar
• Spyer G, Hattersley AT, Sykes JE, Sturley RH, MacLeod KM. Influence of maternal and fetal glucokinase mutations in gestational diabetes. Am. J. Obstet. Gynecol. 185, 240–241 (2001).
   Google Scholar
• McCarthy MI, Menzel S. The genetics of Type 2 diabetes. Br. J. Clin. Pharm. 51, 195–199 (2001).
   Google Scholar
• Risch N. Searching for genetic determinants in the new millennium. Nature 405, 847–856 (2000).
   Google Scholar
• •• An eloquent exposition of the challenges and opportunities associated with finding genes for complete traits with an emphasis on the relative merits of linkage- and association-based approaches.
   Google Scholar
• International Human Genome Sequencing Consortium. Initial sequencing and analysis of the human genome. Nature 409, 860–921 (2001).
   PubMedGoogle Scholar
• Sachidanandam R, Weissman D, Schmidt SC et al. A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms. Nature 409, 928–933 (2001).
   Google Scholar
• Reich DE, Cargill M, Bolk S et al. Linkage disequilibrium in the human genome. Nature 411, 199–204 (2001).
   PubMedGoogle Scholar
• Roses AD. Pharmacogenetics and the practice of medicine. Nature 405, 857–865 (2000).
   Google Scholar
• Cox NJ, Frigge M, Nicolae DL et al. Loci on chromosomes 2 (NIDDM1) and 15 interact to increase susceptibility to diabetes in Mexican Americans. Nature Genet. 21, 213–215 (1999).
   Google Scholar
• Almasy L, Blangero J. Multipoint quantitative-trait linkage analysis in general pedigrees. Am. J. Hum. Genet. 62, 1198–1211 (1998).
   Google Scholar
• Lander ES, Schork NJ. Genetic dissection of complex traits. Science 265, 2037–2048 (1994).
   Google Scholar
• •• A sound introduction to the issues and technologies relevant to gene discovery in complex traits that remains highly pertinent to current debates in the field.
   Google Scholar
• Altshuler D, Hirschhorn JN, Klannemark M et al. The common PPAR Pro12Ala polymorphism is associated with decreased risk of Type 2 diabetes. Nature Genet. 26, 76–80 (2000).
   PubMedGoogle Scholar
• • A study of the role of the common Pro12Ala variant in the PPAR variant in T2D that has set the standard for association studies for complex traits.
   Google Scholar
• Huxtable SJ, Saker PJ, Haddad L et al. Analysis of parent-offspring trios provides evidence for linkage and association between the insulin gene and Type 2 diabetes mediated exclusively through paternally transmitted class III variable number tandem repeat alleles. Diabetes 49, 126–130 (2000).
   Google Scholar
• Hanis CL, Boerwinkle E, Chakraborty R et al. A genome-wide search for human non-insulin-dependent Type 2 diabetes genes reveals a major susceptibility locus on chromosome 2. Nature Genet. 13, 161–171 (1996).
   Google Scholar
• Horikawa Y, Oda N, Cox NJ et al. Genetic variation in the gene encoding calpain-10 is associated with Type 2 diabetes mellitus. Nature Genet. 26, 163–175 (2000).
   Google Scholar
• •• A true-life story of the challenges and methodologies associated with the (successful) search for a T2D susceptibility gene in Mexican American families.
   Google Scholar
• Altshuler D, Daly M & Kruglyak L. Guilt by association. Nature Genet. 26, 135–137 (2000).
   Google Scholar
• • An illuminating and provocative commentary [44].
   Google Scholar
• Wiltshire S, Hattersley AT, Hitman GA et al. A genome-wide scan for loci predisposing to Type 2 diabetes in a UK population (The Diabetes (UK) Warren 2 Repository): analysis of 573 pedigrees provides independent replication of a susceptibility locus on chromosome 1q. Am. J. Hum. Genet. 69, 553–569 (2001).
   Google Scholar
• • The most recent genome scan report for T2D based on analysis of almost 600 pedigrees which provides an up-to-date assessment of progress in the field.
   Google Scholar
• Hanson RL, Ehm MG, Pettitt DJ et al. An autosomal genomic scan for loci linked to Type II diabetes mellitus and body-mass index in Pima Indians. Am. J. Hum. Genet. 63, 1124–1132 (1998).
   Google Scholar
• Ghosh S, Watanabe RM, Valle TT et al. The Finland-United States Investigation of non-insulin-dependent diabetes mellitus genetics FUSION study. I. An autosomal genome scan for genes that predispose to Type 2 diabetes. Am. J. Hum. Genet. 67, 1174–1185 (2000).
   Google Scholar
• Hirschhorn JN, Lindgren CM, Daly MJ et al. Genomewide linkage analysis of stature in multiple populations reveals several regions with evidence of linkage to adult height. Am. J. Hum. Genet. 69, 106–116 (2001).
   Google Scholar
• Collins FS. Positional cloning moves from the perditional to traditional. Nature Genet. 9, 347–350 (1995).
   Google Scholar
• Risch N, Merikangas K. The future of genetic studies of complex human diseases. Science 273, 1516–1517 (1996).
   Google Scholar
• • A seminal paper making the theoretical case for undertaking genome-wide scans for association (as opposed to scans for linkage).
   Google Scholar
• Todd JA. Tackling common disease. Nature 411, 537–539 (2001).
   Google Scholar
• Rippin JD, Patel A, Bain SC. Genetics of diabetic nephropathy. Best Pract. Res. Clin. Endocrinol. Met. 15, 345–358 (2001).
   Google Scholar
• Pritchard JK. Are rare variants responsible for susceptibility to complex diseases? Am. J. Hum. Genet. 69, 124–137 (2001).
   Google Scholar
• Hugot J-P, Chamaillard M, Zouali H et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohns disease. Nature 411, 599–603 (2001).
   PubMedGoogle Scholar
• • A paper describing a recent success in the positional cloning of a complex trait susceptibility gene. Interestingly, the two successful groups [56] used complementary approaches to arrive at the same variants.
   Google Scholar
• Ogura Y, Bonen DK, Inohara N et al. A frameshift mutation in NOD2 associated with susceptibility to Crohns disease. Nature 411, 603–607 (2001).
   Google Scholar
• • See[55].
   Google Scholar
• Evans JC, Frayling TM, Cassell PG et al. Association studies of the calpain-10 gene with Type 2 diabetes mellitus in the United Kingdom. Am. J. Hum. Genet. 69, 544–552 (2001).
   Google Scholar
• • Manuscript describing efforts to reproduce the findings of [44] in a UK data set, neatly illustrating some of the difficulties associated with replicating association and linkage results.
   Google Scholar
• Barroso I, Gurnell M, Crowley VEF et al. Dominant negative mutations in human PPAR associated with severe insulin resistance, diabetes mellitus and hypertension. Nature 402, 880–883 (1999).
   Google Scholar
• Owen K, Hattersley AT. Maturity-onset diabetes of the young: from clinical description to molecular genetic characterization. Best Pract. Res. Clin. Endocrinol. Met. 15, 309–323 (2001).
   Google Scholar
• •• A comprehensive and up-to-date treatise on MODY.
   Google Scholar